A prospective study on clinicians' attitudes and survival outcomes for patients with NSCLC and poor performance status in the immunotherapy era: PICASO study (GOIRC-04-2020)

被引：0
|
作者：
Facchinetti, F. [1 ]
Camerini, A. [2 ]
Bennati, C. [3 ]
Bordi, P. [4 ]
De Carlo, E. [5 ]
Mazzoni, F. [6 ]
Metro, G. [7 ]
Bertolini, F. [8 ]
Longo, L. [9 ]
Ricciardi, S. [10 ]
Pilotto, S. [11 ]
Bria, E. [12 ]
Giardina, D. [13 ]
Passiglia, F. [14 ]
Cortinovis, D. L. [15 ]
Scotti, V. [16 ]
Novello, S. [17 ]
Tognetto, M. [1 ]
Di Maio, M. [18 ]
Tiseo, M. [19 ]
机构：
[1] Grp Oncol Italiano Ric Clin, Med Oncol, Parma, Italy
[2] Osped Versilia, Dept Med Oncol, Lido Di Camaiore, Italy
[3] Osped Santa Maria Croci, Med Oncol, Ravenna, Italy
[4] Osped Maggiore Parma, Med Oncol, Parma, Italy
[5] CRO Aviano Ctr Riferimento Oncol IRCCS, Oncol, Aviano, Italy
[6] AOUC Azienda Osped Univ Careggi, Dept Oncol, Florence, Italy
[7] Osped S Maria Misericordia, Dept Med Oncol, Perugia, Italy
[8] Azienda Osped Univ Policlin Modena, Dept Oncol, Modena, Italy
[9] Nuovo Osped Sassuolo, Med Oncol, Sassuolo, Italy
[10] Azienda Osped S Camillo Forlanini, Med Oncol, Rome, Italy
[11] UNIVR Univ Verona, Dept Med, Med Oncol Sect, Verona, Italy
[12] Fdn Policlin Univ Agostino Gemelli IRCCS, Translat Med & Surg Dept, Rome, Italy
[13] Osped Ramazzini, Med Oncol, AUSL Modena, Carpi, Italy
[14] Univ Torino Orbassano, Dept Oncol, Orbassano, Italy
[15] Osped San Gerardo, ASST Monza, Dipartimento Oncol Med, Monza, Italy
[16] Azienda Osped Univ Careggi, Dept Oncol, Florence, Italy
[17] Univ Torino Orbassano, Dept Oncol, Orbassano, Italy
[18] Univ Turin, Dept Oncol, AOU Citta Salute & Sci Torino, Osped Molinette, Turin, Italy
[19] Azienda Osped Univ Parma, Dept Med Oncol, Parma, Italy
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
关键词：
D O I：
10.1016/j.annonc.2024.08.1404
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1349P
引用
收藏
页码：S852 / S853
页数：2
相关论文
共 39 条
  • [1] Improved Survival of Elderly Patients with NSCLC Treated in the Immunotherapy Era: A Historical Cohort Study
    Pelizzari, G.
    Targato, G.
    Corvaja, C.
    Fantin, A.
    De Maglio, G.
    Rossetto, C.
    Rizzato, S.
    Fasola, G.
    Follador, A.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S998 - S999
  • [2] Effect of SBRT plus immunotherapy on immune status and survival quality of NSCLC patients: A study of combined radiotherapy and immunotherapy
    Shao, Liang
    Gao, Ying
    Zhang, Dan
    Yang, Mengdan
    Jiang, Mimi
    Li, Hongfeng
    Yan, Yanting
    TECHNOLOGY AND HEALTH CARE, 2025, 33 (01) : 485 - 494
  • [3] Front-line erlotinib in unselected patients with advanced NSCLC and poor performance status - the TOPICAL study
    Karachaliou, Niki
    Wei, Jia
    Marques, Ana Daniela
    Rosell, Rafael
    TRANSLATIONAL LUNG CANCER RESEARCH, 2013, 2 (01) : 58 - 61
  • [4] Association between Chinese Medicine Therapy and Survival Outcomes in Postoperative Patients with NSCLC: A Multicenter, Prospective, Cohort Study
    WANG Xue-qian
    ZHANG Ying
    HOU Wei
    WANG Ying-tian
    ZHENG Jia-bin
    LI Jie
    LIN Li-zhu
    JIANG Yi-lan
    WANG Shen-yu
    XIE Ying
    ZHANG Hong-liang
    SHU Qi-jin
    LI Ping
    WANG Wei
    YOU Jian-liang
    LI Ge
    LIU Jie
    FAN Hui-ting
    ZHANG Mei-ying
    LIN Hong-sheng
    Chinese Journal of Integrative Medicine , 2019, (11) : 812 - 819
  • [5] Association between Chinese Medicine Therapy and Survival Outcomes in Postoperative Patients with NSCLC: A Multicenter, Prospective, Cohort Study
    Wang Xue-qian
    Zhang Ying
    Hou Wei
    Wang Ying-tian
    Zheng Jia-bin
    Li Jie
    Lin Li-zhu
    Jiang Yi-lan
    Wang Shen-yu
    Xie Ying
    Zhang Hong-liang
    Shu Qi-jin
    Li Ping
    Wang Wei
    You Jian-liang
    Li Ge
    Liu Jie
    Fan Hui-ting
    Zhang Mei-ying
    Lin Hong-sheng
    CHINESE JOURNAL OF INTEGRATIVE MEDICINE, 2019, 25 (11) : 812 - 819
  • [6] Association between Chinese Medicine Therapy and Survival Outcomes in Postoperative Patients with NSCLC: A Multicenter, Prospective, Cohort Study
    WANG Xueqian
    ZHANG Ying
    HOU Wei
    WANG Yingtian
    ZHENG Jiabin
    LI Jie
    LIN Lizhu
    JIANG Yilan
    WANG Shenyu
    XIE Ying
    ZHANG Hongliang
    SHU Qijin
    LI Ping
    WANG Wei
    YOU Jianliang
    LI Ge
    LIU Jie
    FAN Huiting
    ZHANG Meiying
    LIN Hongsheng
    Chinese Journal of Integrative Medicine, 2019, 25 (11) : 812 - 819
  • [7] Association between Chinese Medicine Therapy and Survival Outcomes in Postoperative Patients with NSCLC: A Multicenter, Prospective, Cohort Study
    Xue-qian Wang
    Ying Zhang
    Wei Hou
    Ying-tian Wang
    Jia-bin Zheng
    Jie Li
    Li-zhu Lin
    Yi-lan Jiang
    Shen-yu Wang
    Ying Xie
    Hong-liang Zhang
    Qi-jin Shu
    Ping Li
    Wei Wang
    Jian-liang You
    Ge Li
    Jie Liu
    Hui-ting Fan
    Mei-ying Zhang
    Hong-sheng Lin
    Chinese Journal of Integrative Medicine, 2019, 25 : 812 - 819
  • [8] Impact of PD-L1 Status on Survival on Immunotherapy Monotherapy in Real-World Patients with Poor Performance Status: A US Nationwide Veterans Affairs Study
    Wu, J.
    Su, C.
    La, J.
    Corrigan, J.
    Das, M.
    Do, N.
    Brophy, M.
    Ahmed, S.
    Han, S.
    Fillmore, N.
    Kelley, M.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (03) : E11 - E12
  • [9] Overall Survival after Radiotherapy for Brain Metastases According to ECOG Status-A Prospective Study of 294 NSCLC Patients
    Karlsson, Astrid Telhaug
    Hjermstad, Marianne Jensen
    Aass, Nina
    Skovlund, Eva
    Kaasa, Stein
    Yri, Olav Erich
    CANCERS, 2024, 16 (08)
  • [10] Circulating miRNAs and PD-L1 Tumor Expression Are Associated with Survival in Advanced NSCLC Patients Treated with Immunotherapy: a Prospective Study
    Boeri, Mattia
    Milione, Massimo
    Proto, Claudia
    Signorelli, Diego
    Lo Russo, Giuseppe
    Galeone, Carlotta
    Verri, Carla
    Mensah, Mavis
    Centonze, Giovanni
    Martinetti, Antonia
    Sottotetti, Elisa
    Pastorino, Ugo
    Garassino, Marina Chiara
    Sozzi, Gabriella
    CLINICAL CANCER RESEARCH, 2019, 25 (07) : 2166 - 2173
1234